Retatrutide
$79.99In Stock
Retatrutide (LY3437943) is a first-in-class triple receptor agonist targeting the GIP, GLP-1, and glucagon pathways — one of the most actively studied next-generation reference compounds in metabolic research.
Most Popular
Best Value
In stock
Sun, Aug 16 – Thu, Aug 20
≥ 99% purity
scannable per batch
Volume Pricing
Research Overview
Retatrutide (LY3437943) is a first-in-class triple receptor agonist that simultaneously targets the GIP, GLP-1, and glucagon receptors. This combined mechanism distinguishes it from single- and dual-agonist incretin compounds and has made it one of the most actively studied next-generation molecules in metabolic research.
Preclinical and early research has examined retatrutide across energy-balance regulation, glucose metabolism, hepatic-lipid endpoints, and body-composition models, positioning it as a widely referenced reference compound in incretin and metabolic-pathway investigation.
Intended Use & Legal Disclaimer
This compound is strictly intended for in vitro laboratory research. It is not for use in humans or animals. Not to be used in foods, drugs, or medical diagnostics.
This product has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. Usage is restricted to certified laboratories and qualified research professionals.
Terms of Sale
All sales by Codex Research are final. Buyers must be qualified professionals and assume full responsibility for safe handling and regulatory compliance. Every batch is independently verified by accredited third-party laboratories. Batch-specific Certificates of Analysis are available on our COAs page.
For Research Use Only · Not for Human Consumption
Be the first to review “Retatrutide”
Related products
Research Peptides
Semaglutide is a long-acting GLP-1 receptor agonist and one of the most extensively characterized reference compounds in metabolic and appetite-signaling research.
Research Peptides
Melanotan-2 (MT-2) is a synthetic analog of alpha-melanocyte-stimulating hormone, studied as a melanocortin receptor agonist in pigmentation and appetite-signaling research.
Research Peptides
Tesamorelin is a stabilized 44-amino-acid GHRH analog studied across growth-hormone-axis, pituitary-function, and metabolic research as a reference GHRH compound.
Research Peptides
TB-500 is a synthetic fragment of Thymosin Beta-4, widely studied as a reference peptide in actin-regulation, tissue-repair, and recovery research models.
Research Peptides
Semax is a short ACTH-derived peptide studied across cognitive, neuroprotective, and BDNF-pathway research as a reference nootropic peptide.
Research Peptides
BPC-157 is a synthetic pentadecapeptide derived from a protective protein sequence found in gastric juice — one of the most widely referenced compounds in tissue-repair and cytoprotection research.
Research Peptides
NAD+ is an essential redox coenzyme central to cellular energy metabolism, studied extensively across mitochondrial-function, DNA-repair, and longevity research.
Research Peptides
Tirzepatide is a dual GIP and GLP-1 receptor agonist — a leading next-generation reference compound in metabolic, glycemic, and body-composition research.
Reviews
There are no reviews yet.